Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-29
DOI
10.3389/fonc.2021.672677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
- (2021) Peng Bai et al. OncoImmunology
- Association between smoking history and tumor mutation burden in advanced non-small cell lung cancer
- (2021) Xinan Wang et al. CANCER RESEARCH
- pVACtools: a computational toolkit to identify and visualize cancer neoantigens
- (2020) Jasreet Hundal et al. Cancer Immunology Research
- Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes
- (2020) Tianshi Lu et al. Science Immunology
- Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy
- (2020) Ilenia Aversa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
- (2020) Mary A. Wood et al. Genome Medicine
- Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
- (2020) Qingzhu Jia et al. Advanced Science
- Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma
- (2020) Hirokazu Matsushita et al. Journal for ImmunoTherapy of Cancer
- Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer
- (2020) Tao Jiang et al. Translational Lung Cancer Research
- Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
- (2020) Timothy V. Pham et al. Molecular Oncology
- Antitumour dendritic cell vaccination in a priming and boosting approach
- (2020) Alexandre Harari et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study
- (2020) Kaichao Feng et al. Journal for ImmunoTherapy of Cancer
- A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients
- (2020) Yanhua Tian et al. BMC Medicine
- Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma
- (2020) Huayu Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
- (2020) Alberto Puccini et al. CLINICAL CANCER RESEARCH
- In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters
- (2020) Inken Salewski et al. Journal of Translational Medicine
- The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
- (2020) Alexej Ballhausen et al. Nature Communications
- Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma
- (2020) Junjie Jiang et al. Cancer Medicine
- Radiotherapy enhances responses of lung cancer to CTLA-4 blockade
- (2019) Anna Wilkins et al. Journal for ImmunoTherapy of Cancer
- Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma
- (2019) Tanner M. Johanns et al. OncoImmunology
- A transcriptionally distinct CXCL13+CD103+CD8+ T-cell population is associated with B-cell recruitment and neoantigen load in human cancer
- (2019) Hagma H Workel et al. Cancer Immunology Research
- Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma
- (2019) Zhihua Gong et al. Journal of Thoracic Oncology
- New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
- (2019) Daniela Criscuolo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
- (2019) Fangjun Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunogenic neoantigens derived from gene fusions stimulate T cell responses
- (2019) Wei Yang et al. NATURE MEDICINE
- The Tumor Immune Microenvironment Drives a Prognostic Relevance that Correlates with Bladder Cancer Subtypes
- (2019) Carolin Pfannstiel et al. Cancer Immunology Research
- Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy
- (2019) FRANZISKA BLAESCHKE et al. CYTOTHERAPY
- Clinical and immunological implications of frameshift mutations in lung cancer
- (2019) Young Kwang Chae et al. Journal of Thoracic Oncology
- Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses
- (2019) Anthony E. Zamora et al. Science Translational Medicine
- Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
- (2019) Anna Morena D’Alise et al. Nature Communications
- Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
- (2019) Claire Lhuillier et al. Genome Medicine
- Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity
- (2019) Felix L. Fennemann et al. Frontiers in Immunology
- T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors
- (2019) Donjete Simnica et al. OncoImmunology
- UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
- (2019) Yochai Wolf et al. CELL
- Immune Activation in Mismatch Repair Deficient Carcinogenesis: More Than Just Mutational Rate
- (2019) Jason A. Willis et al. CLINICAL CANCER RESEARCH
- Direct Detection and Quantification of Neo-antigens
- (2019) Qing Wang et al. Cancer Immunology Research
- pTuneos: prioritizing tumor neoantigens from next-generation sequencing data
- (2019) Chi Zhou et al. Genome Medicine
- Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
- (2019) Elaine R. Mardis Genome Medicine
- DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
- (2019) Jingcheng Wu et al. Frontiers in Immunology
- Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma
- (2019) Sophie Sneddon et al. OncoImmunology
- High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets
- (2019) Xiaoshan M. Shao et al. Cancer Immunology Research
- Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information
- (2018) S Kim et al. ANNALS OF ONCOLOGY
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response
- (2018) Daniel Temko et al. JOURNAL OF PATHOLOGY
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- DNA mismatch repair in cancer
- (2018) Marina Baretti et al. PHARMACOLOGY & THERAPEUTICS
- Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
- (2018) Janos L. Tanyi et al. Science Translational Medicine
- Systematic Analysis of Splice-Site-Creating Mutations in Cancer
- (2018) Reyka G. Jayasinghe et al. Cell Reports
- A cloning and expression system to probe T cell receptor specificity and assess functional avidity to neoantigens
- (2018) Zhuting Hu et al. BLOOD
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases
- (2018) Di Wang et al. CANCER RESEARCH
- Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
- (2018) Brendan Bulik-Sullivan et al. NATURE BIOTECHNOLOGY
- Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
- (2018) Qingzhu Jia et al. Nature Communications
- Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy
- (2018) Dengbo Ji et al. Cancer Immunology Research
- Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma
- (2018) Aaron S. Mansfield et al. Journal of Thoracic Oncology
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
- (2017) Giovanni Germano et al. NATURE
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- The evolving genomic landscape of urothelial carcinoma
- (2017) Alexander P. Glaser et al. Nature Reviews Urology
- DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant Entity
- (2017) Enrico Castellucci et al. ONCOLOGIST
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma
- (2017) A Miller et al. Blood Cancer Journal
- Mutations in DNA repair genes are associated with increased neo-antigen load and activated T cell infiltration in lung adenocarcinoma
- (2017) Young Kwang Chae et al. Oncotarget
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers
- (2017) Andrew R. Green et al. Cancer Immunology Research
- PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity
- (2017) Geng Liu et al. GigaScience
- Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma
- (2016) Kent W. Mouw et al. CLINICAL CANCER RESEARCH
- Antigen-specific impairment of adoptive T-cell therapy against cancer: players, mechanisms, solutions and a hypothesis
- (2016) Jose A. Villadangos IMMUNOLOGICAL REVIEWS
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma
- (2016) H. Matsushita et al. Cancer Immunology Research
- Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy
- (2015) P. Maby et al. CANCER RESEARCH
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Tumor-specific CD4+T cells maintain effector and memory tumor-specific CD8+T cells
- (2013) Sarah E. Church et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Radiation Therapy to Convert the Tumor Into an In Situ Vaccine
- (2012) Silvia C. Formenti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started